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Background
Compared to HIV-1, HIV-2 infection is associated with
slower disease progression and transmission, longer
latency period and low or undetectable plasmatic viral
levels. In an attempt to understand underlying reasons
for the varying pathogenicity between HIV-1 and HIV-2
at the molecular level, we analyzed the differences in
codon usage pattern of all nine coding genes.
Materials and methods
Thirty five full length HIV-2 genome sequences depos-
ited during the period 1986-2008 were downloaded
from LANL. The effective number of codons (NC), GC,
GC3s and Relative Synonymous Codon Usage data cor-
responding to each gene were calculated using Codon
W and Correspondence analysis (CA).
Results
The NC for all the nine genes ranged from 43 – 55.2,
indicating that the genes of HIV-2 are also poorly
biased, as has been reported earlier for HIV-1, resulting
in low levels of expression of these proteins in general.
The NC value of the tat gene of HIV-2 was higher than
that HIV-1. The CA of all nine genes revealed that the
factors influencing the expression of different genes
were not the same.
Conclusion
The codon usage pattern of HIV-2 is distinctly different
from that of HIV-1, and appears to be majorly shaped
by the genomic composition rather than translational
selection. The high Nc value of tat is suggestive of a
lower level of expression of the protein in HIV-2 as
compared to HIV-1, implying that this could be one of
the viral factors responsible for lower levels of HIV-2
replication and delayed disease progression.
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